3 📄 Overview An evidence-based SaMD delivered via mobile app, providing personalized therapeutic interventions (e.g., CBT, mindfulness, exposure therapy principles) for individuals experiencing mild-to-moderate anxiety, depression, or stress. It adapts content based on user progress, integrates passive data from smartphone usage patterns and optionally wearables (e.g., HRV), and offers secure, asynchronous clinician support for higher-acuity cases. Key technologies: 👤 Target users: 👍 Benefits Increased access to evidence-based mental health support • Reduced symptoms of anxiety and depression • Improved stress resilience and coping mechanisms • Reduced burden on traditional mental healthcare systems Use bullets or new lines. 👎 Challenges Achieving and maintaining high user adherence over time • Clinical validation of efficacy against traditional therapies • Establishing clear reimbursement pathways and prescription models • Addressing potential for user privacy concerns with sensitive data 📋 Regulatory & Validation Classified as SaMD (likely Class II) requiring clinical trials to support efficacy claims for treating or managing mental health conditions. • Strict adherence to data privacy regulations (HIPAA, GDPR) for sensitive mental health data. • Robust cybersecurity measures are non-negotiable.